22.10.2021 17:32:00

Why Moderna Stock Is Falling Today

Shares of Moderna (NASDAQ: MRNA) were falling 5.4% as of 11 a.m. EDT on Friday. The decline came after Deutsche Bank (NYSE: DB) initiated coverage on the stock with a sell rating. The investment firm set a price target for Moderna of $250, roughly 26% below the closing price on Thursday.It's not surprising that the vaccine stock dropped after Deutsche Bank's announcement. What might be at least a little surprising is how much more pessimistic the firm is compared to many other Wall Street analysts. The consensus price target for Moderna is close to $340, roughly in line with the stock's closing price yesterday.Image source: Getty Images.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

Analysen zu Moderna Incmehr Analysen

16.09.21 Moderna Buy Goldman Sachs Group Inc.
07.05.21 Moderna overweight Barclays Capital
11.12.20 Moderna buy Goldman Sachs Group Inc.
29.07.20 Moderna buy Goldman Sachs Group Inc.
27.07.20 Moderna buy Goldman Sachs Group Inc.

Eintrag hinzufügen

Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!

Aktien in diesem Artikel

Moderna Inc 294,50 21,67% Moderna Inc
pagehit